Clinical experiences with carboplatin (paraplatin) in lung cancer

Seminars in Oncology

Volumn 19, Issue 1 SUPPL. 2, 1992, Pages 1-11

  Bunn Jr , Paul A ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; REVIEW; SMALL CELL CARCINOMA;

CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CISPLATIN; HUMAN; LUNG NEOPLASMS;

EID: 0026820943     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. The expanding role of cisplatin in the treatment of non-small cell lung cancer
2. Chemotherapy in small cell lung cancer
3. Concurrent chemotherapy/radiotherapy for limited small cell lung carcinoma: A Southwest Oncology Group Study
4. Carboplatin as a single agent and in combination in the treatment of small cell lung cancer
5. High dose carboplatin in the treatment of lung cancer and mesothelioma. A phase I dose escalation study
6. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma
7. First line carboplatin (CBDCA) 24 hours infusion in patients (PTS) with disseminated oat cell carcinoma of the lung
8. Phase II study of carboplatin in small cell lung cancer
9. Phase II study of cisdiammine-1,1-cyclobutane dicarboxylato platinum II (CBDCA, NSC 241240) in non-small cell and small cell lung cancer
10. Phase II study of carboplatin
11. A phase II study of carboplatin in small cell lung cancer
12. Phase II study of carboplatin for lung cancer A cooperative study group in Japan
13. Carboplatin: Current status and future prospects
14. Carboplatin combination chemotherapy regimens for undifferentiated small cell lung cancer
15. Carboplatin and etoposide combination chemotherapy in small cell lung carcinoma
16. Phase I/II trial of etoposide and carboplatin in untreated extensive small cell lung cancer
17. Phase II trial of high dose etoposide and carboplatin in extensive small cell lung cancer
18. A phase II study of teniposide and carboplatinum in patients with limited and extensive small cell lung cancer
19. The National Cancer Institute of Canada experience with etoposide plus carboplatin in previously untreated patients with extensive small cell lung cancer
20. Standard combination chemotherapy versus two carboplatin containing regimens in SCLC A randomized phase II study
21. Carboplatin + ifosfamide in untreated metastatic small cell lung carcinoma
22. Combination chemotherapy of small cell lung cancer: A phase II trial with carboplatin/vincristine/etoposide
23. Carboplatin, vincristine, and etoposide in small cell lung cancer: A phase II trial in previously untreated patients
24. Carboplatin, etoposide and vincristine plus/minus GM-CSF in the treatment of small cell lung cancer
25. Randomized phase III study with carboplatin, etoposide and vincristine versus etoposide and vincristine as first line treatment in extensive small cell lung cancer
26. Carboplatin, methotrexate, and vinblastine: A low toxicity regimen with minimal alopecia for poor risk small cell lung carcinoma
27. Carboplatin in small cell lung cancer: The Royal Marsden Hospital experience
28. Carboplatin, VP-16 and ifosfamide intensive chemotherapy for small cell lung carcinoma. A phase II study
29. A phase II study of VP-16, carboplatin, cyclophosphamide, vincristine (ECCO) in previously untreated patients with small cell lung cancer
30. Carboplatin, ifosfamide, and etoposide with midcourse vincristine for limited stage small cell carcinoma of the bronchus
31. Alternating chemotherapy with doxorubicin, ifosfamide, and vincristine plus cisplatin and etoposide versus doxorubicin, ifosfamide and vincristine plus carboplatin and etoposide in small cell lung cancer
32. Carboplatin and VP-16-213 in previously untreated patients with small cell lung cancer
33. Alternating scheme of chemotherapy with carboplatin, VP-16, ifosfamide, doxorubicin and vincristine plus radiotherapy in the treatment of small cell lung cancer. Preliminary results
34. Phase II trial with carboplatin in patients with advanced unresectable non-small cell lung cancer
35. Combination chemotherapy versus carboplatin or iproplatin followed by combination chemotherapy in stage IV non-small cell lung cancer: An Eastern Cooperative Oncology Group Study
36. Phase II trial of carboplatin in non-small cell lung cancer
37. Iproplatin (CHIP) or carboplatin (CBDCA) in extensive non-small cell lung cancer (NSCLC)
38. Randomized phase II trial of carboplatin vs iproplatin in solid tumors
39. Carboplatin: Current status and future prospects
40. Phase II study of carboplatin for lung cancer A cooperative study group in Japan
41. A phase II study of a 24-hour infusion of carboplatin in patients with non-small cell lung cancer
42. JM 8 development and clinical projects
43. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer
44. Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer. A report of the Canadian Multicenter Trial
45. Carboplatin in non-small cell lung cancer: The Cancer and Leukemia Group B experience
46. Carboplatin and vinblastine in advanced non-small cell lung cancer: A phase II study
47. VP16/carboplatin therapy in advanced non-small cell lung cancer: A phase II study
48. Carboplatin and etoposide in advanced or recurrent non-small cell lung cancer
49. Phase II trial with carboplatin/etoposide in inoperable, extensive non-small cell lung cancer
50. A phase II study evaluating carboplatin plus etoposide in advanced non-small cell lung cancer
51. A randomized study comparing cisplatin or carboplatin plus etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861
52. Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer
53. A randomized trial of induction chemotherapy and high dose radiation therapy in stage III non-small cell lung cancer
54. The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal node metastases (N2Mo)
55. Cisplatin and vindesine combination for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
56. Trial of the combination of mitomycin, vindesine and cisplatin in patients with advanced non-small cell lung cancer
57. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma
58. Surgical adjuvant therapy of non-small cell lung cancer